1 / 33

In the name of God

In the name of God. هورمون ها. اهداف آموزشی هورمونها تعریف هورمون 2- ساختمان ، بافت مترشح و بافت هدف را یاد بگبرد 3-نحوه انتقال هورمونها را بداند 4-متابولیسم -5ختلال ناشی از افزایش و کاهش ترشح هر کدام از هورمونها را بداند. 8-تستهای ازمایشگاهی هورمون ها هورمونهای پپتیدی

quincy
Download Presentation

In the name of God

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. In the name of God

  2. هورمون ها • اهداف آموزشی هورمونها • تعریف هورمون • 2- ساختمان ، بافت مترشح و بافت هدف را یاد بگبرد • 3-نحوه انتقال هورمونها را بداند • 4-متابولیسم • -5ختلال ناشی از افزایش و کاهش ترشح هر کدام از هورمونها را بداند. • 8-تستهای ازمایشگاهی هورمون ها • هورمونهای پپتیدی • هومونهای استروییدی • هومونهای مشتق از اسید آمینه

  3. Hypothalamuses-pituitary axis • Hypothalamose • -pituitary stalk ADH, OX Pituitary hormones

  4. Posterior Pituitary (neurohypophysis) • Cell bodies in SON (ADH) & PVN (Oxytocin) of hypothalamus • Consists of neural endings with • associated blood vessels • Acts as storage area, secretory • granules travel down axon • Connects to hypothalamus via • hypothalamic-hypophyseal tract • Processes extend through infundibulum and end in Post. Pit

  5. Primary positive signal Fig. 4-10A Page 117

  6. Pituitary hormones hypothalamus-Pituitary axis Prolactin GH Prolaction Structure function .

  7. Regulation of prolactin

  8. Laboratory tests • Variation secretion • TRH stimulate production • Normal level in women (up to 20ng/ml/12ng/ml • Prolactin Excess In women:Milk production(galactorrhea), amenorrhes) In Men:Infertility, and impotence,Rarely breast enlargment(Gynecomastia) >200ng/ml: Pituitary tumores 100-200ng/ml: tumors 20-100: diurnal variation,medications,stress,…

  9. Prolactin levels

  10. Growth hormones • Structure • Function -Indirect -Direct

  11. Regulation

  12. Prolactin levels • Marked diurnal Variation

  13. Laboratory data • GH Levels (single mea. Unless 1 h sleep) • RESPONSE TO Physiologic and pharmacologic changesS • STIMULATORS:Exersise,Insulu Hypogly.GHRH(1mg/kg,clonidine(4mg/kg),l-dopa(0.5g)argenine(0.5g/kg) • IGF-I and binding proteins • IGF-1 best marker),<5 year very low • Inhibition:liver disease,acute illoness,malnutreitient

  14. Laboratory evaluation • GH over production • Pituitary tumore (gigantism,acromegaly) • Other effects:thickening, In.sweating,oilness of skin,hypertention,joint paint,hyperglecia • GH deficiency

  15. Sampling • Transfering • Blood increase • Blood decrease

  16. Evolution of Adrenal function • Introduction • Hypothalamic-pituitary-glucocorticosteroid Axis • Biosynthesis • Glococorticoids • Mineral corticoids • Sex Hormones • Regulations

  17. Direct tests of the hypothalamic –pituitary –adrenal Axis • Cortisol,ACTH(stress) • Cortisol(not specific), Synthetic stroids,CBG change. (↓Liver disease, malnutrition, ↑Est, pregnancy.) Urine Free cortisol Plasma cortisol exceeds protein binding capacity, ref.(20-90µg/day) Corticosteroid intermediates Evaluation for suspected congenital adrenal hyperplasia or carcinoma(17-hydroxysteriods, ). Adrenal Androgen production DHEA_S (plasma, urine), Testesteron (gonads),Weak androgens(from gonads and adrenal(measured)

  18. Dynamic tests of the hypothalamic-pituitary-adrenal Axis • Dexamethasone suppression tests (DST) • 1-Overnight DST(1 mg Dexa.). • 2-Low doseDST(0.5 mg/6 h/2d) • 3-high dose(2mg/6h/2d) • Stimulatory stimulation • 1- Cortrosyn stimulation(250 µg/0,30,60 min. after injection),7µg to 18-20 µg, normal,1µgphysiological dose? • 2-Metyrapone Test(inhibites last step in cortisol synthesis) • 3-Insulin hypoglycemia(Insulin,0.05-0.1 u/kg) • 4- corticotropin –releasing hor. stimulation

  19. Abnormalities of Glu. production • Suspected Cushing syndrome (excess Glu. Obesity, hypertention,virilization,hyperglycemia(hypokalemia and metabolic alkalosis may?) Diagnosis of Cushing syndrome UFC or Overnight DS Adrenal insufficiency Mineral cor. (dehydration, hyponatremia, hyperkalemia, non-anion gap metyabolic acidosis.) Glu. Deficeincy(weight loss, vometing, weakness) Primary insufficiency(addison disease). Pigmentation skin(POMC) Secondary adrenal insuficiency(pituitary). Neither min nor excess ACTH is present(Hyperglecimia) Diagnosing adrenal insufficiency Cortisol measument(18-20µg ruling out) Trea. Administration dexametasine, cotrosyn)

  20. Congenital adrenal hyperplasia • 21-hydroylase deficiency • 11-hydroxylase deficiency

  21. Laboratory tests of mineral and metabolism Plasma calcium Total and active form (PH,complexing anion) Adjusted Ca(mg/dl)=totalCa(mg/dL)+0.8x(4-Albumin(g/dL) Free Calcium?

  22. Phosphate • Variation(Throuhgout the day and after meals↓) • Single assay? • Renal failure? • Monoclonal gammopathies • Magnesium • Plasma equilibrates with cell magnesium

  23. PTH • Mid-molecule or C-terminal assay measure long-lived,inactive metabolite • Renal failure? • PTH assay? • Vitamin D assay • 25-Hydroxyvitamin D assay proportion to deficiency or toxicity • 1,25 Dihydroxyvitamin D(suspected ectopic) • PTHr • Urinary Mineral Excretion

  24. Hypercalcemia • Artifactual(protein bound)hypercalcemia • Primary hyperparathyroidism • Hypercalcemia of Malignancy • Uncommon causes of hypercalcemia

  25. Hypocalcemia • Artfactual • Chronic Renal failure • Uncommon causes (hypoPTH,Hypomagnesemia)

  26. Hyperphosphatemia • Renal failure • Uncommon causes(HypoPTH,Vitamin D Toxicity,hyperthyroidism,Cell lysis sydromes)

  27. hypophosphatemia • Osteoporosis • Vitamin D defiemcy • Paget,s disease • Renal Osteodystrophy

  28. Metabolic Bone disease

More Related